Last update 10 Jun 2025

Onterodrimer

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
KB-195-Kaleido Biosciences, KB 195, KB195
Target-
Action
modulators
Mechanism
Microbiome modulators
Therapeutic Areas
Other Diseases
Active Indication
Hyperammonemia
Inactive Indication
N-Acetyl Glutamate Synthetase Deficiency
Originator Organization
Kaledio Biosciences
Active Organization
Kaledio Biosciences
Inactive Organization
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Onterodrimer
Login to view more data
100 Translational Medicine associated with Onterodrimer
Login to view more data
100 Patents (Medical) associated with Onterodrimer
Login to view more data
100 Deals associated with Onterodrimer
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
United States
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
Belgium
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
Germany
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
Spain
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
Switzerland
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
Turkey
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
N-Acetyl Glutamate Synthetase DeficiencyPhase 2
United Kingdom
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
17 Sep 2019
HyperammonemiaPhase 2
Switzerland
Kaleido Biosciences, Inc.Kaleido Biosciences, Inc.
31 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free